ClinicalTrials.govpublic full text
Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Cancer
glioma, astrocytoma, glioblastoma, antineoplastic agents, herpes virus, brain tumor, oncolytic virs, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 887844
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.